Ocean Biomedical Debuts as Publicly Traded Company Focused on Accelerating the Commercialization of Innovative Assets from Research Universities and Medical Centers Completes business combination with Aesther Healthcare Acquisition Corp. Ocean Biomedical stock will trade on Nasdaq under ticker symbol "OCEA" Providence, RI and New York, NY, Feb. 15, 2023 ...

Aesther Healthcare Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Business Combination New York, NY and Providence, RI, Sept. 19, 2022 (GLOBE NEWSWIRE) -- As previously announced, on August 31, 2022, Aesther Healthcare Acquisition Corp. (“Aesther”) (NASDAQ: AEHA) entered into...

DAV addresses VA's infrastructure realignment recommendations WASHINGTON, D.C., March 17, 2022 (GLOBE NEWSWIRE) -- Earlier this week, the Department of Veterans Affairs (VA) issued a series of recommendations to the Asset and Infrastructure Review (AIR)...

IMAC Holdings, Inc. to Present at H.C. Wainwright BIOCONNECT Virtual Conference BRENTWOOD, Tenn., Jan. 04, 2022 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) today announced that Jeffrey Ervin, Chief Executive Officer of IMAC, will present at the H.C. Wainwright...

Daxor Corporation Announces Further Acquisitions of its BVA-100® Blood Volume Analyzer by Leading Medical Centers Throughout the U.S. NEW YORK, NY, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...